Persistent Asset Partners LTD Janux Therapeutics, Inc. Transaction History

Persistent Asset Partners LTD

  • $121 Billion
  • Q4 2024

A detailed history of Persistent Asset Partners LTD transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 53 shares of JANX stock, worth $1,542. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53
Holding current value
$1,542
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

About Janux Therapeutics, Inc.

JANX Quotes by TradingView
  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $1.21B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Persistent Asset Partners LTD Portfolio

Follow Persistent Asset Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Persistent Asset Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Persistent Asset Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email